Ai-Ming Yu (Aiming Yu)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 37

Top Topics

Drug Administration

Small Cell Lung Cancer

Hyaluronic Acid

Prostate Cancer

Top Venues

Nature communications

Molecular pharmacology

RNA (New York, N.Y.)

ACS synthetic biology

This page only lists publications with an associated author ORCID identifier.

Publications

Gavin M Traber, Ai-Ming Yu
The Growing Class of Novel RNAi Therapeutics. Molecular pharmacology 106 (1) (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Gavin M Traber, Colleen Yi, Neelu Batra, Meijuan Tu, Ai-Ming Yu
Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents. RNA (New York, N.Y.) (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Neelu Batra, Mei-Juan Tu, Ai-Ming Yu
Molecular Engineering of Functional SiRNA Agents. ACS synthetic biology 13 (6) (2024)
Gavin M Traber, Colleen Yi, Neelu Batra, Mei-Juan Tu, Ai-Ming Yu
Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents. RNA (New York, N.Y.) 30 (6) (2024)
Gavin M Traber, Colleen Yi, Neelu Batra, Mei-Juan Tu, Ai-Ming Yu
Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents. RNA (New York, N.Y.) 30 (6) (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Neelu Batra, Mei-Juan Tu, Ai-Ming Yu
Molecular Engineering of Functional SiRNA Agents. ACS synthetic biology 13 (6) (2024)
Neelu Batra, Mei-Juan Tu, Ai-Ming Yu
Molecular Engineering of Functional SiRNA Agents. ACS synthetic biology 13 (6) (2024)
Neelu Batra, Mei-Juan Tu, Ai-Ming Yu
Molecular Engineering of Functional SiRNA Agents. ACS synthetic biology (2024)
Gavin M Traber, Colleen Yi, Neelu Batra, Mei-Juan Tu, Ai-Ming Yu
Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents. RNA (New York, N.Y.) 30 (6) (2024)
Gavin M Traber, Ai-Ming Yu
The Growing Class of Novel RNAi Therapeutics. Molecular pharmacology 106 (1) (2024)
Gavin M Traber, Ai-Ming Yu
The Growing Class of Novel RNAi Therapeutics. Molecular pharmacology 106 (1) (2024)
Gavin M Traber, Colleen Yi, Neelu Batra, Mei-Juan Tu, Ai-Ming Yu
Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents. RNA (New York, N.Y.) 30 (6) (2024)
Gavin M Traber, Ai-Ming Yu
The Growing Class of Novel RNAi Therapeutics. Molecular pharmacology 106 (1) (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Gavin M Traber, Colleen Yi, Neelu Batra, Mei-Juan Tu, Ai-Ming Yu
Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents. RNA (New York, N.Y.) 30 (6) (2024)
Gavin M Traber, Ai-Ming Yu
The Growing Class of Novel RNAi Therapeutics. Molecular pharmacology 106 (1) (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Gavin M Traber, Ai-Ming Yu
The Growing Class of Novel RNAi Therapeutics . Molecular pharmacology (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Joseph Cronin, Ai-Ming Yu
Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research. Drug metabolism and disposition: the biological fate of chemicals (2023)
Shu Ning, Chengfei Liu, Wei Lou, Joy C Yang, Alan P Lombard, Leandro S D'Abronzo, Neelu Batra, Ai-Ming Yu, Amy R Leslie, Masuda Sharifi, Christopher P Evans, Allen C Gao
Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide Treatment. Molecular cancer therapeutics 21 (10) (2022)
Gavin M Traber, Ai-Ming Yu
RNAi Based Therapeutics and Novel RNA Bioengineering Technologies . The Journal of pharmacology and experimental therapeutics (2022)
Shu Ning, Jinge Zhao, Alan P Lombard, Leandro S D'Abronzo, Amy R Leslie, Masuda Sharifi, Wei Lou, Chengfei Liu, Joy C Yang, Christopher P Evans, Eva Corey, Hong-Wu Chen, Ai-Ming Yu, Paramita M Ghosh, Allen C Gao
Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomes. Communications medicine 2 (2022)
Anastasia L Berg, Ashley Rowson-Hodel, Michelle Hu, Michael Keeling, Hao Wu, Kacey VanderVorst, Jenny J Chen, Jason Hatakeyama, Joseph Jilek, Courtney A Dreyer, Madelyn R Wheeler, Ai-Ming Yu, Yuanpei Li, Kermit L Carraway
The Cationic Amphiphilic Drug Hexamethylene Amiloride Eradicates Bulk Breast Cancer Cells and Therapy-Resistant Subpopulations with Similar Efficiencies. Cancers 14 (4) (2022)
Chengfei Liu, Cameron M Armstrong, Shu Ning, Joy C Yang, Wei Lou, Alan P Lombard, Jinge Zhao, Chun-Yi Wu, Ai-Ming Yu, Christopher P Evans, Clifford G Tepper, Pui-Kai Li, Allen C Gao
ARVib suppresses growth of advanced prostate cancer via inhibition of androgen receptor signaling. Oncogene 40 (35) (2021)
Xiong Zhang, Zenghong Huang, Jun-Jian Wang, Zhao Ma, Joy Yang, Eva Corey, Christopher P Evans, Ai-Ming Yu, Hong-Wu Chen
Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR Signaling. Cancers 13 (7) (2021)
Young Hee Choi, Chao Zhang, Zhenzhen Liu, Mei-Juan Tu, Ai-Xi Yu, Ai-Ming Yu
A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism. The Journal of pharmacology and experimental therapeutics 377 (3) (2021)
Mei-Juan Tu, Zhijian Duan, Zhenzhen Liu, Chao Zhang, Richard J Bold, Frank J Gonzalez, Edward J Kim, Ai-Ming Yu
MicroRNA-1291-5p Sensitizes Pancreatic Carcinoma Cells to Arginine Deprivation and Chemotherapy through the Regulation of Arginolysis and Glycolysis. Molecular pharmacology 98 (6) (2020)
Ai-Ming Yu, Neelu Batra, Mei-Juan Tu, Colleen Sweeney
Novel approaches for efficient in vivo fermentation production of noncoding RNAs. Applied microbiology and biotechnology 104 (5) (2020)
Joseph L Jilek, Mei-Juan Tu, Chao Zhang, Ai-Ming Yu
Pharmacokinetic and Pharmacodynamic Factors Contribute to Synergism between Let-7c-5p and 5-Fluorouracil in Inhibiting Hepatocellular Carcinoma Cell Viability. Drug metabolism and disposition: the biological fate of chemicals 48 (12) (2020)
Neelu Batra, Cristabelle De Souza, Jyoti Batra, Alan G Raetz, Ai-Ming Yu
The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19). International journal of molecular sciences 21 (17) (2020)
Hannah Petrek, Ai-Ming Yu
MicroRNAs in non-small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential. Pharmacology research & perspectives 7 (6) (2020)
Hannah Petrek, Neelu Batra, Pui Yan Ho, Mei-Juan Tu, Ai-Ming Yu
Bioengineering of a single long noncoding RNA molecule that carries multiple small RNAs. Applied microbiology and biotechnology 103 (15) (2019)